TIDMAKT

RNS Number : 9025I

Ark Therapeutics Group PLC

09 July 2013

Ark Therapeutics Group plc

Company Update

London, UK, 9 July 2013 - Ark Therapeutics Group plc (LSE: AKT) ("Ark") confirms that the contract with Crawford Healthcare relating to the sale of the Woundcare Business sold to Crawford Healthcare in 2011 has been terminated and in return for an immediate payment of GBP300,000 Ark has agreed to release Crawford Healthcare from any future obligations under the contract.

David Venables, Non-Executive Director commented: "We have reached an amicable agreement which benefits both parties."

For further information please contact:

 
 Ark Therapeutics Group plc            Tel: +44 (0)207 002 1005 
 Iain G Ross, Non-Executive Chairman 
 David Venables, Non-Executive 
  Director

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding Ark's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond Ark's control that could cause the actual results, performance or achievements of Ark to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding Ark's present and future business strategies and the environment in which Ark will operate in the future. These forward-looking statements speak only as at the date of this announcement. Ark expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in Ark's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLIFVADVIAIIV

Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Premier Veterinary Charts.
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Premier Veterinary Charts.